Free Trial

Nautilus Biotechnology (NAUT) Insider Trading & Ownership

Nautilus Biotechnology logo
$2.61
+0.01 (+0.38%)
(As of 11/1/2024 ET)

Nautilus Biotechnology (NASDAQ:NAUT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
40.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$108,316.27
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$234,728.97
Get NAUT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nautilus Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NAUT Insider Buying and Selling by Quarter

Nautilus Biotechnology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/23/2024Mary E. GodwinVPSell47,031$2.87$134,978.97  
9/17/2024Mary E. GodwinVPSell35,000$2.85$99,750.00  
3/11/2024Sujal M PatelCEOBuy12,044$2.84$34,204.96  
3/7/2024Sujal M PatelCEOBuy18,854$2.89$54,488.06  
3/5/2024Sujal M PatelCEOBuy7,405$2.65$19,623.25  
(Data available from 1/1/2013 forward)

NAUT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Nautilus Biotechnology includes Anna Mowry, Gwen E Weld, Mary E. Godwin, Matthew B Murphy, Matthew L Posard, Matthew S Mcilwain, Perceptive Advisors Llc, Subramanian Sankar, and Sujal M Patel. Learn more on insiders at NAUT.

40.50% of Nautilus Biotechnology stock is owned by insiders. Learn more on NAUT's insider holdings.

The following insider purchased NAUT shares in the last 24 months: Sujal M Patel ($108,316.27).

Insiders have purchased a total of 38,303 NAUT shares in the last 24 months for a total of $108,316.27 bought.

The following insider sold NAUT shares in the last 24 months: Mary E. Godwin ($234,728.97).

Insiders have sold a total of 82,031 Nautilus Biotechnology shares in the last 24 months for a total of $234,728.97 sold.

Nautilus Biotechnology Key Executives



This page (NASDAQ:NAUT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners